Thrombolytics for Acute Ischemic Stroke - 2024
This activity provides an overview of the pharmacology, administration, and monitoring of alteplase and tenecteplase for thrombolytic therapy in patients with acute ischemic stroke, and precautions for using these medications in various clinical scenarios, as well as the application of evidence-based guidelines and best practices to optimize patient outcomes.
Target Audience
- Physicians
- Advanced Practice Nurses
- Physician Assistant
- Registered Nurses
Learning Objectives
Learners will be able to:
- Describe the indications for thrombolytics use.
- Identify high/low-risk settings for use of thrombolytics.
- Describe the decision-making process for thrombolytics use.
Igor Malenky, MD, MS
Debra Chionis, MS, ACE-MES, ACSM-CEP
Robert Fishman, MD
Caitlyn Boyd, MHA, MSN, RN, CPHQ, CPAHA-TeleStroke
Muhammad Saeed, Bcom
Available Credit
- 1.00 AMA PRA Category 1 Credit™
TeleSpecialists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
TeleSpecialists designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Nursing Contact HoursThis nursing continuing professional development activity was approved by the Emergency Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.